- Home
- WHF vs PRE Comparison
WHF vs PRE Comparison
Compare WHF & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHF
- PRE
- Stock Information
- Founded
- WHF 2011
- PRE 2014
- Country
- WHF United States
- PRE Hong Kong
- Employees
- WHF N/A
- PRE N/A
- Industry
- WHF Finance Companies
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- WHF Finance
- PRE Industrials
- Exchange
- WHF Nasdaq
- PRE Nasdaq
- Market Cap
- WHF 162.2M
- PRE 131.3M
- IPO Year
- WHF 2012
- PRE N/A
- Fundamental
- Price
- WHF $7.09
- PRE $13.69
- Analyst Decision
- WHF Hold
- PRE Buy
- Analyst Count
- WHF 4
- PRE 1
- Target Price
- WHF $9.17
- PRE $9.00
- AVG Volume (30 Days)
- WHF 153.0K
- PRE 129.5K
- Earning Date
- WHF 11-10-2025
- PRE 11-26-2025
- Dividend Yield
- WHF 25.36%
- PRE N/A
- EPS Growth
- WHF N/A
- PRE N/A
- EPS
- WHF 0.15
- PRE N/A
- Revenue
- WHF $81,499,000.00
- PRE $57,051,000.00
- Revenue This Year
- WHF N/A
- PRE $202.46
- Revenue Next Year
- WHF N/A
- PRE $103.60
- P/E Ratio
- WHF $46.00
- PRE N/A
- Revenue Growth
- WHF N/A
- PRE 151.74
- 52 Week Low
- WHF $6.53
- PRE $3.10
- 52 Week High
- WHF $12.18
- PRE $17.99
- Technical
- Relative Strength Index (RSI)
- WHF 44.48
- PRE 48.02
- Support Level
- WHF $6.96
- PRE $14.50
- Resistance Level
- WHF $7.20
- PRE $17.84
- Average True Range (ATR)
- WHF 0.21
- PRE 1.32
- MACD
- WHF 0.09
- PRE -0.16
- Stochastic Oscillator
- WHF 76.39
- PRE 12.16
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.